Lv3
350 积分 2021-03-04 加入
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
2天前
已完结
Carbapenemases: epidemiology, detection and management in a changing global landscape
24天前
已关闭
Optimizing therapy of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae
1个月前
已完结
Fitness cost of ceftazidime–avibactam resistance acquisition in carbapenem-resistant hypervirulent Klebsiella pneumoniae
5个月前
已完结
Sodium load of novel antibiotics: considerations for nephrologists and clinicians
5个月前
已完结
Cost-minimizing alternative dosage regimens of imipenem/cilastatin/relebactam for patients with renal impairment: a pharmacokinetic/pharmacodynamic simulation study
5个月前
已完结
Stability of ceftolozane and tazobactam in different peritoneal dialysis solutions
5个月前
已完结
[Clinical Characteristics and Survival Analysis of Carbapenem-Resistant Pseudomonas Aeruginosa Colonized or Infected Patients with Hematological Disorders]
8个月前
已关闭
Management of MDR/XDR severe infections in the critically ill
9个月前
已关闭
A Tentative Clinical Study: Colistin Combined with Ceftazidime/Avibactam in the Treatment of Carbapenem-Resistant Gram-Negative Bacilli Infection
10个月前
已完结
皖公网安备34019202002308
